1. Sweden Stocks

  2. •

    Health technology

  3. •

    Medical specialties
Enzymatica AB

Enzymatica AB

0.16
EUR
0.00
(0.00%)
-0.02EPS
57.04MMarket Cap
Oct 29Next Earn
Enzymatica AB
GETTEX:EN9
(Gettex)

Recent

price

0.16

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
SEK
0.02
0.04
0.04
0.47
0.68
0.91
0.51
0.6
0.51
0.4
0.72
0.36
0.29
0.29
0.24
0.22
0.19
Revenue per Share
-0.12
-0.39
-0.38
-0.73
-1.15
-1.33
-0.62
-0.32
-0.41
-0.27
-0.09
-0.29
-0.41
-0.28
-0.28
-0.21
-0.21
Basic EPS, GAAP
-0.45
-0.38
-0.52
-1.03
-1.59
-1.33
-0.73
-0.24
-0.28
-0.25
-0.1
-0.27
-0.41
-0.23
-0.32
-0.17
-0.16
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.34
0.22
0.76
0.81
2.5
0.72
1.4
1.09
1.03
0.77
0.69
0.77
0.71
0.43
0.73
0.51
0.4
Book Value per Share
0.28
0.17
0.56
0.4
2.05
0.27
0.42
0.15
0.45
0.23
0.18
0.31
0.31
0.05
0.45
0.25
0.14
Tangible Book Value per Share
13
13
20
22
28
31
72
98
103
155
155
159
167
178
193
243
243
Basic Weighted Avg Shares
- -
1
1
10
19
28
36
59
53
61
111
57
49
51
46
54
45
Sales/Revenue/Turnover
-473.28
-845.19
-857.09
-154.53
-171.36
-145.16
-126.57
-50.82
-77.21
-67.95
-10.84
-79.04
-139.37
-94.42
-114.22
-95.3
-113.61
Operating Margin (%)
- -
- -
- -
- -
1
1
3
5
6
7
7
7
8
7
6
5
- -
Depreciation Expense
-2
-5
-8
-16
-32
-41
-45
-31
-43
-41
-13
-45
-69
-50
-53
-52
-52
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-515.45
-856.87
-845.59
-154.52
-169.93
-146.28
-123.36
-52.9
-81.01
-66.84
-11.88
-79.3
-140.27
-97.69
-116.68
-96.27
-114.83
Profit Margin (%)
5
3
10
7
51
8
43
15
68
30
18
34
58
6
94
47
32
Working Capital
2
- -
- -
- -
- -
- -
7
4
3
3
2
1
21
17
1
- -
12
LT Debt
4
3
14
16
62
22
142
111
160
119
107
125
126
77
176
124
98
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-129.27
-87.12
-108.83
-82.9
-96.74
-55
-24.95
-31.54
-29.39
-11.71
-39.2
-54.65
-49.02
-42.04
-34.53
-40.52
Return on Common Equity (%)

Capital Structure

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
1
1
3
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
12
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
243
243
243
Market Capitalization
438
735
632

Working Capital

SEK

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
65
52
36
Cash, Cash Equivalents & STI
33
26
13
Accounts Receivable, Net
10
6
4
Inventories
19
16
14
Total Current Liabilities
18
7
5
Payables & Accruals
- -
- -
- -
ST Debt
1
1
3
Deferred Revenue
- -
- -
- -

Growth Rates

SEK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
61.19%
15.91%
-29.59%
Free Cash Flow
17.96%
42.26%
-32.34%
Net Income, GAAP
21.56%
54.31%
-2.42%
Sales/Revenue/Turnover
12.89%
-10.25%
18.27%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
9
6
13
17
46
2025
12
8
- -
18
54
2026
11
7
- -
- -
- -

Quarterly Earnings Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-0.1
-0.07
-0.04
-0.05
-0.28
2025
-0.07
-0.06
- -
-0.05
-0.21
2026
-0.06
-0.05
- -
- -
- -

Quarterly Dividends Per Share

SEK

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Intuitive Surgical, Inc. (NASDAQ:ISRG)
Boston Scientific Corporation (NYSE:BSX)
Thermo Fisher Scientific Inc (NYSE:TMO)
Illumina, Inc. (NASDAQ:ILMN)
Abbott Laboratories (NYSE:ABT)
GRAIL, Inc. (NASDAQ:GRAL)
Business
I did not find relevant search results specifically about the recent major changes or detailed company description of Enzymatica AB (publ) (Ticker: ENZY.ST). I will search again focusing specifically on up-to-date details regarding Enzymatica AB's products, services, operations, and recent developments.